Pre-clinical studies employing both in vitro and animal models suggest that they mostly act by inhibiting MMP-2 and MMP-9 or their related pathways, indicating that polyphenolic compounds have considerable potential against the development and progression of cancers. The gene discussed is MMP2; the disease is cancer.